SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 5.91 |
| Enterprise Value ($M) | -0.34 |
| Book Value ($M) | 6.56 |
| Book Value / Share | 3.75 |
| Price / Book | 0.90 |
| NCAV ($M) | 6.00 |
| NCAV / Share | 3.43 |
| Price / NCAV | 0.98 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.81 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.12 |
| Current Ratio | 19.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 6.33 |
| Assets | 6.89 |
| Liabilities | 0.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 24,124 | 71,346 | 33.81 | |
| 50,412 | 161,399 | 31.23 | |
| 35,836 | 117,228 | 30.57 | |
| 52,002 | 133,564 | 38.93 | |
| 7,261 | 28,536 | 25.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CDTX – Cidara Therapeutics, Inc. | CDXC – ChromaDex Corporation |
| CELU – Celularity Inc. | CGEN – Compugen Ltd. |
| CING – Cingulate Inc. |
Financial data and stock pages provided by
Fintel.io